Generated by GPT-5-mini| Payment by Results (England) | |
|---|---|
| Name | Payment by Results (England) |
| Introduced | 2003 |
| Country | England |
| Administered by | Department of Health and Social Care |
| Related | NHS England, Monitor, Care Quality Commission |
Payment by Results (England) Payment by Results (PbR) is a funding mechanism introduced in England to allocate payments to National Health Service (England) providers based on activity and complexity. Developed during the administrations of Tony Blair and Gordon Brown and implemented by the Department of Health and Social Care, the system sought to link funding to measurable outputs in National Health Service (NHS) England, influencing organisations such as Monitor (NHS) and the Care Quality Commission. It intersected with policy debates involving figures like Alan Milburn, Clare Gerada, Nigel Crisp, and institutions including NHS Trusts, Foundation Trusts, and Clinical Commissioning Groups.
PbR emerged amid wider reforms following reports by Derek Wanless and commissions such as the King's Fund inquiries, aiming to translate recommendations from Health Select Committee (House of Commons) debates into operational funding. Proponents referenced international models from Medicare (United States), Australian Medicare, and payment reforms in Canada to justify activity-based tariffs. The approach responded to pressures identified in reviews by Institute for Fiscal Studies, concerns raised during the tenure of Alan Milburn and later John Reid, and prior commissioning experiments in regions like Manchester and Birmingham. Policymakers argued that links to outputs would address issues noted in analyses by Audit Commission and National Audit Office.
Design drew on classifications such as Healthcare Resource Groups (HRGs) and tariff-setting by bodies akin to NICE guidance processes. Implementation required coordination among NHS Information Authority, Connecting for Health, Department of Health and Social Care policy teams, and financial regulators like Monitor (NHS). Early pilots involved trusts including Guy's and St Thomas' NHS Foundation Trust and Addenbrooke's Hospital, with national roll-out timed alongside structural changes promoted in White Papers associated with Tony Blair and ministers like Alan Milburn and Patricia Hewitt. Technical tools from Office for National Statistics datasets and coding standards from ICD-10 and OPCS-4 underpinned tariff calculation and activity recording.
In practice, commissioners such as Clinical Commissioning Groups and national bodies including NHS England contracted with providers—NHS Trusts, Foundation Trusts, and independent sector partners—using PbR tariffs. The mechanism interfaced with regulatory frameworks of Monitor (NHS), quality assessment by Care Quality Commission, and workforce considerations involving unions like Royal College of Nursing and British Medical Association. Hospitals across regions including London, Manchester, Leeds, and Newcastle upon Tyne adapted coding and management systems, while national programmes such as Choose and Book and Payment by Results shadowing supported transition.
Studies from institutions like King's Fund, Nuffield Trust, and academics at London School of Economics and University College London assessed PbR effects on waiting times, elective activity, and case-mix. Some analyses linked PbR to reductions in waiting list lengths and increases in elective procedures at hospitals such as Royal Free Hospital and St Thomas' Hospital, citing comparative evaluations by the National Institute for Health and Care Excellence. Conversely, research from University of Manchester and reports for British Medical Journal questioned improvements in clinical outcomes and warned of potential unintended consequences documented by Health Foundation and Nuffield Trust studies.
Economists from Institute for Fiscal Studies and Office for Budget Responsibility modelled PbR impacts on NHS finances, noting shifts in activity-based revenues for NHS Trusts and financial incentives affecting capital and operational planning. Tariff adjustments influenced provider behaviour in metropolitan centres like London and provincial hubs such as Bristol and Nottingham. Analyses by National Audit Office and Audit Commission examined cost control, tariff setting, and data quality, while think tanks including Policy Exchange and Centre for Policy Studies debated implications for public spending and efficiency.
Critics from organisations such as British Medical Association, Royal College of Surgeons of England, and Royal College of Physicians highlighted gaming, coding upcoding, and perverse incentives; case studies referenced incidents at trusts including Mid Staffordshire NHS Foundation Trust and controversies scrutinised in inquiries like the Francis Report. Commentators in The Guardian and The Telegraph and academics at University of Birmingham and University of York documented disputes over tariff granularity, equity between regions such as North West England and South East England, and interactions with payment reforms in Wales and Scotland.
Responses included moves toward blended payment models advocated by NHS England and research by Health Foundation, proposals from Nuffield Trust, and pilots integrating capitated budgets led by Integrated Care Systems and initiatives with Clinical Commissioning Groups. Alternatives such as bundled payments trialled in partnership with organisations like King's Fund and value-based procurement discussions influenced policy dialogues involving Department of Health and Social Care ministers and advisors formerly allied with Care Quality Commission reforms. Future trajectories consider integration with digital initiatives from NHS Digital, outcome measures aligned with NICE guidance, and governance changes influenced by reviews from House of Lords committees and fiscal analyses by the Institute for Government.
Category:Health policy in England